• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/37

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

37 Cards in this Set

  • Front
  • Back

T or F about Risk of Colon Cancer: Sporadic Cases> FAP Familiar Risks> Lynch Syndrome >Hamartomatous Polyposis

False: Sporadic Cases> Familiar Risks> Lynch Syndrome> FAP >Hamartomatous Polyposis

Colorectal Cancer:Temporal vs Migratory Trends

Colorectal Cancer: Risk Factors

- Age


- IBD


-Personal history of polyps


- Hereditary Colorectal Cancer syndromes


- Prior abdominal radiation


- AfricanAmerican >Caucasian


- Men > Women


- Acromegaly


- Patients on immunosuppression (renal transplant its)


- Obesity


- Diabetics


- Alcohol


- Cigarette smoking


- Cholecystectomy (right sided colon cancers)


- red meat

Colorectal Cancer: Theory of Causation

Colorectal Cancer: Primary, Secondary, ad Conjugated Bile Acids

Colorectal Cancer: Bile acid Effect on Arachidonic Acid

bile acids stimulate this process (increase PGEs, TXAs)


As a resutlt these increase angiogenesis (tumor has more BV) and decease apoptosis and increase cellular proliferation


NSAIDS and Aspirin can block this pathway, high dose NSAIDS may be a tx

Colorectal Cancer: Protective Factors

Colorectal Cancer: Possible Protective Mechanisms

High fiber diet: Dilutes carcinogens,                                 Minimizes duration ofcontact with mucosa, and May decrease harmfulbacterial enzymes andare fermented by fecalflora to short chain fattyacids (lowers pH whichinhibits carcinogene...

High fiber diet: Dilutes carcinogens, Minimizes duration ofcontact with mucosa, and May decrease harmfulbacterial enzymes andare fermented by fecalflora to short chain fattyacids (lowers pH whichinhibits carcinogenesis).

Colorectal Cancer: Symptoms and Location

Symptom Prevalence by location:
-																						  Ascending colon (25%) - Transverse colon (15% ) 
-Descending (5% ) 
- Sigmoid colon (35%)
- Rectum (20%) 


 Right Colon – Anemia  Left Colon – Rectal Bleeding

Symptom Prevalence by location:


- Ascending colon (25%) - Transverse colon (15% )


-Descending (5% )


- Sigmoid colon (35%)


- Rectum (20%)




Right Colon – Anemia Left Colon – Rectal Bleeding

Colorectal Cancer: Diagnostic Studies

Colorectal Cancer: Colonoscopy

Very Important in Screening and Prevention

Colorectal Cancer: Biology

Abnormal Proliferation: stem cell can mutate (monoclonal mutation to a cancer cell) because of the properties of uncontrolled growth, becomes cancerous.

Abnormal Proliferation: stem cell can mutate (monoclonal mutation to a cancer cell) because of the properties of uncontrolled growth, becomes cancerous.

Types of Polyps

Colorectal Cancer Pathogenesis : Adenoma-Carcinoma Sequence

Colorectal Cancer: Multistep Carcinogenesis

1. Normal Epithelium


2. Hyper proliferative Epithelium (from loss of APC)


4. Early Adenoma


4. Intermediate Adenoma (from Activation of Kras)


5. Late Adenoma (From loss of 18q)


6. Carcinoma (from loss of p53)


7. Metastasis

Molecular Genetics of Colorectal Cancer

Alterations in genetic mechanisms may lead todisruption of the normal cell cycle and cellproliferation.


- Germline mutations(e.g. familial polyposis)


- Somatic mutations (environmental, diet, etc)




Three major classes of genetic changesleading to CRC:


- Alteration in oncogenes


- Loss of tumor suppressor genes


- Abnormal DNA mismatch repair

Colorectal Cancer: Alteration in oncogenes

Colorectal Cancer: Loss of tumor suppressor gene ( affect cell adhesion)

Colorectal Cancer: Loss of tumor suppressor gene (affect cell cycle)

Colorectal Cancer: Loss of tumor suppressor gene (regulated cell adhesion)

Colorectal Cancer: Loss of tumor suppressor gene (Abnormal DNA mismatch repair )

Genes altered in sporadic colorectal cancer

Major Hereditary Colon CancerSyndromes

Clinical features of Lynch Syndrome

Commonly Mutinous and poor differentiated, Dx around 40s
Often Proximal
Hypermutable/ Replication aError Phenotype

Commonly Mutinous and poor differentiated, Dx around 40s


Often Proximal


Hypermutable/ Replication aError Phenotype

Lynch Syndrome: Lifetime Cancer Risks


Amsterdam and Bethesda Criteria

Amsterdam Criteria (3, 2, 1 rule)


- at least 3 family members


- cases must span 2 generations


- one must be a first degree




Bethesda Criteria:


- < 50yo


- HPNCC associated tumors


- MSI-H Histology



Microsatallite Instability (MSI)

MSI – changes in sizes of repetitive stretches of DNAdue to insertion or deletion of repeated units. 
Mismatch repair genes (MLH1 and MSH2) ‐ germline >somatic.																																							   


90% of HNPCC/Lynch																				...

MSI – changes in sizes of repetitive stretches of DNAdue to insertion or deletion of repeated units.


Mismatch repair genes (MLH1 and MSH2) ‐ germline >somatic.




90% of HNPCC/Lynch


15% of sporadic colon cancers

Muir-Torre Syndrome

Variant of Lynch Syndrome


Associated with MSH2 or MLH1


Typical Features of HNPCC and:


- Sebaceous gland tumors (cysts)


- keratoacanthomas

Recommendations for Individuals with lynch Syndrome

Familial Adenomatous Polyposis (FAP)

Familial Adenomatous Polyposis (FAP) Surveillance

Gardner Syndrome

A Variant of FAP




Features of FAP and Extraintestinal lessons


- demoed tumors


- osteomas


- supernumerary teeth


- CHRPE


- Soft tissue skin tumors

Turcot Syndrome

A Variant of FAP or Lynch Syndrome


Rare hereditary syndrome of multiple colorectal adenomas and primary bring tumors


2 Distinct subtypes:


- APC mutations associated with medulloblastoms


- PMS2/MLH1 mutations associated with glioblastoma


Genetic Testing may clarify diagnosis

Peutz-Jeghers Syndrome

- Autosomal Dominant


- STK11 gene on chromosome 19


- GI hamartoma


- Characteristic pigmentation


- 93% overall cancer risk by age 65 years


- cancers include colon, breast, pancreas, stomach, ovaries, and others

Colon Cancer Pathology, Staging, and Prognosis

Duke Classification: ABDC (based on bowel wall penetration, LN, and metastasis)
 
TMN Classification: Stage 0 to 4


Prognosis- 5yr survival: 
0 (100%)
1 (100-80%)
2 (30-70%)
3 (30-60%)
4 (3-30%)

Duke Classification: ABDC (based on bowel wall penetration, LN, and metastasis)



TMN Classification: Stage 0 to 4




Prognosis- 5yr survival:


0 (100%)


1 (100-80%)


2 (30-70%)


3 (30-60%)


4 (3-30%)

Hereditary Pancreatic Cancer




Genes and Associated Conditions

Genes: PRSS1, SPINK1


Associated Diseases:
- HNPCC: Risk of PC is 3‐4% 
- Peutz‐Jeghers Syndrome: Risk of PC of 11‐36% 																								 
- FAP:   Risk unknown

Genes: PRSS1, SPINK1




Associated Diseases:


- HNPCC: Risk of PC is 3‐4%


- Peutz‐Jeghers Syndrome: Risk of PC of 11‐36%


- FAP: Risk unknown

Hereditary Gastric Cancer

Other hereditary syndromes have increased risk ofgastric cancer including:Col


- HNPCC


- FAP


- Peutz‐Jegher